electroCore Announces First Patient Enrollment in Investigator-Led Study of gammaCore™ nVNS for PTSD
electroCore, Inc., a bioelectronic medicine company, announced the enrollment of the first eight patients in an investigator-led clinical study evaluating its gammaCore non-invasive vagus nerve stimulation (nVNS) device as an adjunctive treatment for PTSD symptoms. The study, conducted by Acacia Clinics in collaboration with the Vagus Nerve Society…